Progyny reports third-quarter revenue growth and raises full-year guidance

Progyny reported third-quarter 2026 revenue of $341.25M and reported EPS of $0.32, while adjusted EPS was 52 cents. The company forecast fourth-quarter EPS of 53-58 cents on revenue of $344.7M-$364.7M and full-year EPS of $2.09-$2.13 on revenue of $1.37B-$1.39B. Progyny also said its latest selling season produced 1.3 million new covered lives and over 85 new clients.

The results establish forward revenue and earnings ranges through the fourth quarter and full year, while the new-client and covered-life additions provide operating growth indicators for Progyny. The company said the strong first nine months enabled it to raise the midpoint of full-year guidance.

  • 1Progyny reported third-quarter revenue of $341.25M and EPS of $0.32.
  • 2Adjusted third-quarter EPS was 52 cents.
  • 3Progyny forecast fourth-quarter EPS of 53-58 cents and revenue of $344.7M-$364.7M.
  • 4The company forecast full-year EPS of $2.09-$2.13 on revenue of $1.37B-$1.39B.
  • 5Progyny's selling season generated 1.3 million new covered lives and over 85 new clients.
  • 6Wells Fargo raised its Progyny price target to $38, citing strong sales growth and a record selling season.

Sources